Vistagen therapeutics, inc. (VTGN)
CashFlow / Yearly
Mar'19Mar'18Mar'17Mar'16Mar'15Mar'14Mar'13Mar'12Mar'11
Cash flows from operating activities:
Net loss and comprehensive loss

-24,589

-14,345

-10,255

-47,220

-13,885

-

-

-

-9,482

Net loss

-

-

-

-

-

-2,967

-12,886

-12,209

-

Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization

-

-

-

-

-

54

33

45

45

Amortization of discounts on convertible and promissory notes

-

-

-

-

-

640

254

-

-

Change in warrant liability

-

-

-

-

-

-3,566

1,635

77

-203

Stock-based compensation

-

-

-

-

-

1,137

1,241

1,591

1,628

Depreciation and amortization

91

80

54

53

59

-

-

-

-

Amortization of discounts on convertible and promissory notes

-

-

-

564

3,372

-

-

-

-

Change in warrant liability

-

-

-

1,894

34

-

-

-

-

Stock-based compensation

3,443

2,344

851

4,041

2,460

-

-

-

-

Expense related to modification of warrants, including exchange of warrants for common stock

25

292

427

6,218

98

-

-

-

-

Amortization of deferred rent

-

-

83

-27

-14

-

-

-

-

Fair value of common stock granted for services

391

1,615

1,640

829

469

-

-

-

-

Fair value of common stock granted for services prior to the Merger

-

-

-

-

-

-

-

2,225

-

Fair value of common stock granted for services

-

-

-

-

-

0

340

452

-

Fair value of Series B Preferred stock granted for services

4,250

0

375

1,382

0

-

-

-

-

Amortization of fair value of common stock issued for services

-

-

-

-

-

-

0

131

0

Fair value of warrants granted for services

119

0

240

1,280

44

-

-

-

-

Gain on currency fluctuation

-

-

-

6

63

-

-

-

-

Loss on extinguishment of accounts payable

-22

-135

0

-26,700

-2,388

-

-

-

-

Fair value of common stock issued for note term modification

-

-

-

-

-

-

0

22

0

Consulting services by related parties settled by issuing promissory notes

-

-

-

-

-

-

0

0

0

Loss on disposition of equipment

-

-

-

-2

0

-

0

0

0

Fair value of warrants granted for services and interest

-

-

-

-

-

60

183

564

0

Acquired in-process research and development

-

-

-

-

-

-

-

0

0

Amortization of imputed discount on non-interest bearing notes

-

-

-

-

-

-

-

0

0

Amortization of discounts on 7%, 7.5% and 10% notes

-

-

-

-

-

-

-

57

71

Amortization of discounts on Platinum notes

-

-

-

-

-

-

-

909

1,376

Amortization of discounts on August 2010 short-term notes

-

-

-

-

-

-

-

14

557

Amortization of discounts on February 2012 12% convertible notes

-

-

-

-

-

-

-

-4

0

Gain on currency fluctuation

-

-

-

-

-

-48

-53

-

-

Fair value of additional warrants granted pursuant to exercises of modified warrants

-

-

-

-

-

-

35

138

0

Loss on settlements of accounts payable

-

-

-

-

-

-

78

-

-

Acquired in-process research and development

-

-

-

-

-

-

0

-

-

Loss on extinguishment of debt

-

-

-

-

-

0

3,567

1,193

0

Non-cash rent and relocation expense

-

-

-

-

-

-

0

-

-

Reversal of interest income on note receivable for stock purchase

-

-

-

-

2

-1

-27

0

-

Loss on settlement of note receivable for common stock purchase

-

-

-

-

134

-

-

-

-

Changes in operating assets and liabilities:
Receivable from supplier

300

0

-

-

-

0

-

-

-

Unbilled contract payments receivable

-

-

-

-

-

-

106

-64

205

Prepaid expenses and other current assets

-589

-131

227

-25

-107

92

46

-1

630

Security deposits and other assets

-

-

-

-

-

-17

0

2

4

Accounts payable and accrued expenses

1,338

541

-451

-547

2,024

2,229

1,485

744

4,385

Expense related to modification of warrants, including exchange of warrants for common stock

-

-

-

-

-

204

508

741

0

Deferred rent

-90

-146

-

-

-

-56

-

-

-

Deferred rent

-

-

-

-

-

-

-13

-65

-60

Net cash used in operating activities

-14,527

-9,058

-

-

-

-2,126

-3,463

-3,565

-841

Cash flows from investing activities:
Net cash used in operating activities

-

-

-7,262

-4,808

-2,768

-

-

-

-

Purchases of equipment

174

1

239

26

0

-

-

-

-

Purchases of equipment

-

-

-

-

-

-9

135

32

57

Net cash used in investing activities

-174

-1

-239

-26

-

9

-135

-32

-57

Cash flows from financing activities:
Net proceeds from issuance of common stock and warrants, including Units

17,041

16,722

9,899

280

3,146

1,075

1,185

2,679

0

Net proceeds from issuance of Series B Preferred Units

-

-

278

5,025

0

-

-

0

0

Net proceeds from issuance of Series B Preferred Units

-

-

-

-

-

264

-

-

-

Proceeds from sales of notes and warrants to Platinum

-

-

-

-

-

250

3,222

-

-

Proceeds from exercise of warrants

605

0

-

-

-

-

-

-

-

Proceeds from exercise of modified warrants

-

-

-

-

-

-

262

1,166

-

Advance from officer

-

-

-

-

-

64

0

-

-

Proceeds from issuance of notes under line of credit

-

-

-

-

-

-

0

0

0

Proceeds from issuance of 7% note payable to founding stockholder

-

-

-

-

-

-

0

0

0

Proceeds from issuance of 7%note payable to founding stockholder

-

-

-

-

-

-

-

0

0

Net proceeds from issuance of 7% convertible notes

-

-

-

-

-

-

0

0

0

Net proceeds from issuance of 10% convertible notes and warrants

-

-

-

-

-

-

0

0

0

Net proceeds from issuance of preferred stock and warrants

-

-

-

-

-

-

0

0

0

Net proceeds from issuance of 2008/2010 notes and warrants

-

-

-

-

-

-

-

0

270

Net proceeds from issuance of notes and warrants from 2006 to 2010

-

-

-

-

-

-

0

0

0

Proceeds from issuance of 7% notes payable

-

-

-

-

-

-

-

0

0

Net proceeds from issuance of August 2010 short-term notes and warrants

-

-

-

-

-

-

-

0

800

Net proceeds from issuance of February 2012 12% convertible notes and warrants

-

-

-

-

-

-

0

466

0

Repayment of financing lease obligation

2

2

1

1

3

-7

-16

14

27

Repayment of notes payable

220

203

182

111

303

148

-496

757

205

Net cash provided by financing activities

-

-

9,994

5,193

2,838

-

-

-

-

Net cash provided by financing activities

17,423

16,516

-

-

-

1,497

4,155

3,539

837

Net decrease in cash and cash equivalents

2,722

7,457

2,492

358

70

-638

557

-58

-61

Cash paid for interest

8

8

16

12

35

21

225

265

147

Cash paid for income taxes

2

2

2

2

2

-

-

-

-

Cash paid for income taxes

-

-

-

-

-

2

3

1

1

Forgiveness of accrued compensation and accrued interest payable to officers transferred to equity

-

-

-

-

-

-

0

0

0

Exercise of warrants and options in exchange for debt cancellation

-

-

-

-

-

-

0

0

0

Settlement of accrued and prepaid interest by issuance of Series C Preferred Stock

-

-

-

-

-

-

0

0

0

Conversion of 10% notes payable, net of discount, and related accrued interest of $408,600 into Series C Preferred stock

-

-

-

-

-

-

0

-

-

Conversion of 10% notes payable, net of discount, and related accrued interest into Series C Preferred stock

-

-

-

-

-

-

-

0

0

Issuance of Series B-1 Preferred stock for acquired in-process research and development

-

-

-

-

-

-

0

0

0

Conversion of 7% notes payable, net of discount, and related accrued interest of $3,800 into Series B Preferred stock

-

-

-

-

-

-

0

-

-

Conversion of accounts payable into convertible promissory notes

-

-

-

-

-

-

0

-

-

Conversion of Senior Secured Notes, Subordinate Convertible Notes, Promissory Notes, Accounts payable and other debt into Series B Preferred

-

-

-

18,891

0

-

1,558

-

-

Insurance premiums settled by issuing note payable

224

202

178

79

105

-

-

-

-

Accrued dividends on Series B Preferred

1,139

1,030

1,257

2,140

-

-

-

-

-

Accrued dividends on Series B Preferred settled upon conversion by issuance of common stock

-

-

1,768

50

-

-

-

-

-

Supplemental disclosure of noncash activites:
Conversion of 7% notes payable, net of discount, and related accrued interest into Series B Preferred stock

-

-

-

-

-

-

-

0

0

Conversion of accounts payable into convertible promissory notes

-

-

-

-

-

-

-

0

0

Conversion of accounts payable into note payable

-

-

-

-

-

-

-

0

1,126

Conversion of accounts payable into common stock

-

-

-

-

-

-

103

275

0

Conversion of accrued interest on convertible promissory notes into common stock

-

-

-

-

-

-

0

0

0

Notes receivable from sale of common stock to related parties upon exercise of options and warrants

-

-

-

-

-

-

0

0

0

Capital lease obligations

-

-

-

-

-

-

0

19

0

Recognition of put option and note term extension option liabilities upon issuance of Original Platinum Notes

-

-

-

-

-

-

0

-

-

Recognition of put option and note term extension option liabilities upon issuance of Platinum Notes

-

-

-

-

-

-

-

0

0

Incremental fair value of put option and note term extension option liabilities from debt modifications

-

-

-

-

-

-

0

0

158

Incremental fair value of note conversion option from debt modification

-

-

-

-

-

-

0

0

1,062

Incremental fair value of warrant from debt modifications

-

-

-

-

-

-

0

0

121

Recognition of warrant liability upon adoption of new accounting standard

-

-

-

-

-

-

0

0

0

Fair value of warrants issued with August 2010 short term notes

-

-

-

-

-

-

0

0

130

Note discount upon issuance of August 2010 short term notes

-

-

-

-

-

-

0

0

320

Note Discount upon issuance of August 2010 short-term notes

-

-

-

-

-

-

-

0

320

Fair value of warrants issued with February 2012 12 % convertible notes

-

-

-

-

-

-

0

542

0

Note discount upon issuance of February 2012 12% convertible notes

-

-

-

-

-

-

0

495

0

Conversion of 2006/2007 and 2008/2010 Notes into Units, including accrued interest of $1,365,600

-

-

-

-

-

-

0

-

-

Conversion of 2006/2007 and 2008/2010 Notes into Units, including accrued interest of $1,365,600

-

-

-

-

-

-

-

6,174

-

Conversion of all series of pre-Merger preferred stock into Units

-

-

-

-

-

-

0

14,534

-

Conversion of 2011 Platinum Note into Series A Preferred Stock, including accrued interest of $611,100 and conversion premium

-

-

-

-

-

-

0

-

-

Conversion of 7% note payable and accrued interest of $11,500 into common stock and warrants

-

-

-

-

-

-

0

-

-

Conversion of 2011 Platinum Note into Series A Preferred stock, including accrued interest of $611,100 and conversion premium

-

-

-

-

-

-

-

5,763

-

Conversion of 7% note payable and accrued interest of $11,500 into common stock and warrants

-

-

-

-

-

-

-

19

-

Conversion of accounts payable to Morrison & Foerster, McCarthy Tetrault and Desjardins into notes payable

-

-

-

-

-

-

0

1,603

-

Accounts payable and cancellation premium converted into 2011 Private Placement Units

-

-

-

-

-

-

0

169

-

Accrued interest on Cato Holding Company note converted to note payable

-

-

-

-

-

-

0

90

-

Accounts payable settled in December 2011 and May/June 2012 warrant exercises

-

-

-

-

-

-

12

267

-

Insurance premiums settled by issuing note payable

-

-

-

-

-

98

110

88

-

Deemed dividend from trigger of down round provision feature

0

199

0

-

-

-

-

-

-

Acquisition of equipment under capital lease

40

450

14

0

-

-

-

-

-

Accounts payable settled by issuance of common stock or notes payable and common stock

-

-

-

-

438

-

-

-

-

Conversion of accrued interest and fees on February 2012 Notes into 2012 Private Placement Units

-

-

-

-

-

-

92

0

-

Accrued interest on July and August 2012 Notes to Platinum converted into Exchange Note

-

-

-

-

-

-

22

0

-

Accounts payable settled by issuance of stock or notes payable and stock

-

-

-

-

-

0

104

0

-

Accounts payable converted into 2012 Private Placement Units

-

-

-

-

-

-

50

0

-

Recognition of warrant liability upon issuance to Platinum of July 2013 Senior Secured Convertible Note

-

-

-

-

-

146

1,690

-

-

Recognition of warrant liability for potential issuance to Platinum of Series A Exchange Warrant under the terms of the October 2012 Agreement

-

-

-

-

-

-

3,068

-

-

Recognition of warrant liability upon issuance to Platinum of October 2012 Exchange Note and October 2012, February 2013 and March 2013 Investment Notes

-

-

-

-

-

-

-

0

-

Recognition of warrant liability for potential issuance to Platinum of Series A Exchange Warrant under the terms of the October 2012 Agreement

-

-

-

-

-

-

-

0

-